Search Results - Odeyemi, I.A.O

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Economic Evaluation of Pharmacological Treatments for Overactive Bladder

    Economic Evaluation of Pharmacological Treatments for Overactive Bladder by Posnett, J, Walker, A, Nazir, J, Odeyemi, I.A.O, Hakimi, Z, Garnham, A

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Drug treatment patterns for the management of men with benign prostatic hyperplasia (BPH) who have predominant urgency and frequency symptoms in uk primary care the health improvement network (THIN) data

    Drug treatment patterns for the management of men with benign prostatic hyperplasia (BPH) who have predominant urgency and frequency symptoms in uk primary care the health improvem... by Hakimi, Z, Johnson, M, Thompson, M, Nazir, J, Blak, B.T, Odeyemi, I.A.O

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom: Results from a Trial-Based Model

    Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom: Results from a Trial-Based Model by Aballéa, S, Maman, K, Desroziers, K, Nazir, J, Odeyemi, I.A.O, Hakimi, Z, Garnham, A, Toumi, M

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom

    Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom by Maman, K, Neine, M, Briquet, B, Nazir, J, Odeyemi, I.A.O, Hakimi, Z, Garnham, A, Aballéa, S

    Published in Value in health
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    “Yes”, “No” or “Yes, but”? Multinomial modelling of NICE decision-making

    “Yes”, “No” or “Yes, but”? Multinomial modelling of NICE decision-making by Dakin, Helen Angela, Devlin, Nancy J., Odeyemi, Isaac A.O.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    PUK20 - Economic Evaluation of Pharmacological Treatments for Overactive Bladder

    PUK20 - Economic Evaluation of Pharmacological Treatments for Overactive Bladder by Posnett, J., Walker, A., Nazir, J., Odeyemi, I.A.O., Hakimi, Z., Garnham, A.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    PUK21 - Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom: Results from a Trial-Based Model

    PUK21 - Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom: Results from a Trial-Based Mo... by Aballéa, S., Maman, K., Desroziers, K., Nazir, J., Odeyemi, I.A.O., Hakimi, Z., Garnham, A., Toumi, M.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    PUK22 - Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom

    PUK22 - Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom by Maman, K., Neine, M., Briquet, B., Nazir, J., Odeyemi, I.A.O., Hakimi, Z., Garnham, A., Aballéa, S.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    PUK22 - Drug treatment patterns for the management of men with benign prostatic hyperplasia (BPH) who have predominant urgency and frequency symptoms in uk primary care the health improvement network (THIN) data

    PUK22 - Drug treatment patterns for the management of men with benign prostatic hyperplasia (BPH) who have predominant urgency and frequency symptoms in uk primary care the health... by Hakimi, Z., Johnson, M., Thompson, M., Nazir, J., Blak, B.T., Odeyemi, I.A.O.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: